Charcot foot

New Book from Diabetes Guardians, LLC Written for People with Diabetes Shows How to Recognize Signs and Symptoms So That Timely Intervention Can Be Made to Prevent Diabetic Foot Complications

Retrieved on: 
Monday, August 28, 2023
Knowledge, Diabetes, Amputation, Charcot foot, Infection, Foot, Podiatry, MS, Gangrene, City, DPM, Amazon (company), Health, Clinical, Caregiver, Disease, Pharmaceutical industry

This book offers an insightful and practical guide for managing diabetic foot complications, aiming to help individuals worldwide to lead healthier lives, free from debilitating complications.

Key Points: 
  • This book offers an insightful and practical guide for managing diabetic foot complications, aiming to help individuals worldwide to lead healthier lives, free from debilitating complications.
  • Understanding the hidden link between diabetes and foot health is crucial in preventing severe complications, yet it often remains under-emphasized.
  • Knowledge truly is power when in avoiding diabetic foot complications such as foot ulcers, infections, Charcot foot, gangrene or even amputation," Dr. Han concluded.
  • With over 30 years of clinical experience, his commitment to bettering the lives of individuals with diabetes remains his driving force.

Paragon 28 to Present at The 34th Annual Piper Sandler Healthcare Conference

Retrieved on: 
Wednesday, November 16, 2022
Surgery, Health, Medical Devices, Paragon, Foot, FNA, Ankle, CFO, Conference, Chicken feet, NYSE, Bunion, Recurrence, Charcot foot, Business

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will participate in a fireside chat at the 34th Annual Piper Sandler Healthcare Conference on Thursday, December 1, 2022 at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will participate in a fireside chat at the 34th Annual Piper Sandler Healthcare Conference on Thursday, December 1, 2022 at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time.
  • A live webcast, as well as the archived recording, will be available on the investor relations section of the Companys website at ir.paragon28.com.
  • Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives.
  • The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Paragon 28 To Report Third Quarter 2022 Financial Results on November 10, 2022

Retrieved on: 
Thursday, October 27, 2022
Surgery, Health, Medical Devices, Paragon, Chicken feet, Bunion, FNA, NYSE, Foot, Ankle, Charcot foot, Webcast, Recurrence, Medical device

Paragon 28, Inc. (NYSE: FNA) (PARAGON), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced it will report financial results for the third quarter 2022 after market close on Thursday, November 10, 2022.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA) (PARAGON), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced it will report financial results for the third quarter 2022 after market close on Thursday, November 10, 2022.
  • The companys management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time.
  • Live audio of the webcast will be available on the Investors section of the companys website at: ir.paragon28.com .
  • Based in Englewood, Colo., Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives.

Paragon 28 to Present at The Morgan Stanley 20th Annual Global Healthcare Conference

Retrieved on: 
Thursday, August 25, 2022
General Health, Health, Other Health, Medical Devices, Paragon, CEO, NYSE, Charcot foot, Business, Morgan, Morgan Stanley, Recurrence, Bunion, FNA, Chicken feet, CFO, Conference, Ankle, Foot

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be presenting at the Morgan Stanley 20th Annual Global Healthcare Conference.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be presenting at the Morgan Stanley 20th Annual Global Healthcare Conference.
  • Mr. DaCosta and Mr. Deitsch will be hosting a fireside chat presentation on Tuesday, September 13th, 2022, at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.
  • A live webcast, as well as the archived recording, will be available on the investor relations section of the Companys website at ir.paragon28.com.
  • Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives.

Paragon 28 Announces Changes to its Board of Directors

Retrieved on: 
Thursday, August 4, 2022
Biotechnology, Health, Surgery, Medical Devices, Paragon, Grace College & Seminary, ATEC, Zimmer Biomet, CEO, Recurrence, NYSE, NuVasive, Board, Chicken feet, Financial compensation, Charcot foot, Company, Corporation, Foot, FNA, NASDAQ, Certified Public Accountant, Scott, Board of directors, IRTC, Bunion, Head, Ankle, Audit committee, Management, Director, Dexcom, Accounting, IPO

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced two changes to the composition of its Board of Directors.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced two changes to the composition of its Board of Directors.
  • Quentin Blackford has joined the Companys Board of Directors and will serve the Company as Chairman of its Compensation Committee and as a member of its Audit Committee.
  • We are very excited to have Quentin join our Board of Directors, said Albert DaCosta, CEO and Chairman of Paragon 28.
  • I am very grateful to Scott for his service to Paragon 28.

Paragon 28 to Present at The Canaccord Genuity 42nd Annual Growth Conference

Retrieved on: 
Monday, July 18, 2022
Biotechnology, Health, Surgery, Medical Devices, Paragon, Recurrence, CEO, Canaccord Genuity, NYSE, Conference, Ankle, Eastern Time Zone, Charcot foot, FNA, Bunion, Foot, CFO, Chicken feet

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will be presenting at The Canaccord Genuity 42nd Annual Growth Conference in Boston.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will be presenting at The Canaccord Genuity 42nd Annual Growth Conference in Boston.
  • The Canaccord Genuity fireside chat will be webcast live on August 11, 2022, at 1:00pm Eastern Time.
  • A live webcast, as well as the archived recording, will be available on the investor relations section of the Companys website at ir.paragon28.com.
  • Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives.

Paragon 28 To Report Second Quarter 2022 Financial Results on August 3, 2022

Retrieved on: 
Monday, July 18, 2022
Health, Surgery, Other Health, Medical Devices, Paragon, Bunion, NYSE, Recurrence, Charcot foot, Foot, Chicken feet, FNA, Ankle, Webcast, Medical device

Paragon 28, Inc. (NYSE: FNA) (PARAGON), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 3, 2022.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA) (PARAGON), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 3, 2022.
  • The companys management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time.
  • Live audio of the webcast will be available on the Investors section of the companys website at: ir.paragon28.com .
  • Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives.

Paragon 28 Launches Mobile Medical Education Lab Tour, Expanding Opportunities for Foot and Ankle Surgeon Education

Retrieved on: 
Wednesday, July 13, 2022
Education, Medical Devices, Health, Surgery, General Health, Training, Paragon, Ankle, FNA, Surgeon, Education, Multimedia, Bunion, CEO, Chicken feet, Entrepreneurship, Business, City, Recurrence, NYSE, Foot, Charcot foot, Mobile phone operator, Hospital

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced its new nationwide mobile training lab tour, for convenient, on-site surgeon training and education.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced its new nationwide mobile training lab tour, for convenient, on-site surgeon training and education.
  • View the full release here: https://www.businesswire.com/news/home/20220713005137/en/
    Paragon 28 Surgeon Mobile Lab (Photo: Business Wire)
    Paragon 28s new mobile lab is housed in a 43x30 foot tractor-trailer which includes a state-of-the-art, 6-station, cadaveric training facility accommodating up to 20 surgeons.
  • It is important for Paragon 28 to find the most effective venue for medical education to support our growing product portfolio and surgeon customers, said Albert DaCosta, CEO and Co-Founder of Paragon 28.
  • To learn more about the Paragon 28 Surgeon Mobile Lab, please visit the following site: https://paragon28meded.com/p28-mobile-lab-launch?utm_source=press+releas...
    Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives.

Paragon 28 Launches Monkey Rings™ Circular External Fixation System

Retrieved on: 
Thursday, June 9, 2022
General Health, Health, Other Health, Medical Devices, Paragon, Arthritis, Foot, Chicken feet, Trauma, Bunion, Jungle, Multimedia, Charcot foot, Sandwich plate system, Recurrence, FNA, P28, Patient, Hospital, NYSE, Ankle, APEX, Surgeon, Monkey, Deformity, Medical imaging

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the launch of its Monkey Rings Circular External Fixation System for trauma, deformity correction, and limb salvage.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the launch of its Monkey Rings Circular External Fixation System for trauma, deformity correction, and limb salvage.
  • View the full release here: https://www.businesswire.com/news/home/20220613005025/en/
    Monkey Rings Circular External Fixation System (Graphic: Business Wire)
    The Monkey Rings Circular External Fixation System is designed to use external wires and screws that can be fixed into bone to maintain anatomic position while providing stability, preservation of soft tissue, and allow for adjustability and functionality.
  • The Monkey Rings System allows hospitals and surgeons to work with a single vendor for internal fixation, external fixation, wound care, and biologics.
  • The addition of the Monkey Rings Circular External Fixation System bolsters Paragon 28's product offering which includes the Silverback Ankle Fusion Plating System, Gorilla R3CON Plating System, Joust Beaming Screw System, APEX 3D Total Ankle Replacement System, and Phantom TTC Fusion Nail Systems.

Paragon 28 Launches TenoTac™ 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair

Retrieved on: 
Thursday, May 19, 2022
Biotechnology, Health, Surgery, Medical Devices, Paragon, Chicken feet, Foot, JAWS, FNA, Surgeon, Multimedia, Bunion, Contracture, Recurrence, Charcot foot, Titanium, Ankle, NYSE, Hammer toe

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its hammertoe and soft-tissue portfolio with the launch of its TenoTac 2.0 Soft Tissue Fixation System.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its hammertoe and soft-tissue portfolio with the launch of its TenoTac 2.0 Soft Tissue Fixation System.
  • The TenoTac 2.0 Soft Tissue Fixation System uses a titanium threaded implant and was designed to allow for greater capture of soft tissue, streamlined tensioning, and improved fit to the bony surface.
  • TenoTac 2.0 adds to our growing portfolio of soft tissue products and the Hammertoe segment, with opportunities for significant improvements in patient outcomes.
  • The addition of the TenoTac 2.0 Soft Tissue Fixation System bolsters Paragon 28s hammertoe product offering, which includes the Paratrooper Plantar Plate System, HammerTube Hammertoe System, Mini-Monster Screw System, and JAWS Staple System.